Personal Finance
The Survival Odds For Pancreatic Cancer Just Got Better…. A Lot Better! – Equity Insider
In late 2022, Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) Put Out Historically Incredible Numbers in its Latest GOBLET Study, including a Near TRIPLING of Objective Response Rate (ORR), and a Statistically Rare Complete Response (CR)—LEADING TO THE FDA GRANTING FAST TRACK DESIGNATION FOR PELAREOREP. Now ONCY is Going into the 2023 ASCO Annual Meeting with Another…
Read the full article here
-
Side Hustles5 days ago
The DOJ Reportedly Wants Google to Sell Its Chrome Browser
-
Side Hustles5 days ago
How to Create a Unique Value Proposition (With Tips & Examples)
-
Investing4 days ago
Are You Missing These Hidden Warning Signs When Hiring?
-
Investing6 days ago
This Founder Turned a Hangover Cure into Millions
-
Make Money4 days ago
7 Common Things You Should Never Buy New
-
Investing4 days ago
Google faces call from DuckDuckGo for new EU probes into tech rule compliance By Reuters
-
Passive Income5 days ago
How AI Can (and Should) Drive Innovation Across Your Entire Company
-
Investing5 days ago
Barbara Corcoran, Lori Greiner Differ on ‘Quiet Vacationing’